Angiotensin AT1 Receptors and Their Ligands (Review)


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

This review addresses on the most intensely studied biological targets in the body – type 1 angiotensin receptors. Particular attention is focused on receptor structure and its interaction with various intracellular signal molecules. Data on long-known and newly created ligands able to influence AT1 receptors are presented. The individual structural fragments of AT1 antagonist molecules with functional significance for this type of activity are described. The review includes a brief analysis of the potentials for the clinical use of AT1 antagonists in a number of pathological states additional to the registered indications, including arterial hypertension, chronic heart failure, and nephropathy in type 2 diabetes mellitus. These results from the discovery of additional aspects of the mechanism of action of antagonists and their ability to produce effects such as neuroprotective and anti-inflammatory actions, as well as various organ-protective properties.

Авторлар туралы

A. Spasov

Volgograd State Medical University; Volgograd Medical Scientific Center

Email: DYPharm@list.ru
Ресей, Volgograd; Volgograd

D. Yakovlev

Volgograd State Medical University; Volgograd Medical Scientific Center

Хат алмасуға жауапты Автор.
Email: DYPharm@list.ru
Ресей, Volgograd; Volgograd

A. Brigadirova

Volgograd State Medical University; Volgograd Medical Scientific Center

Email: DYPharm@list.ru
Ресей, Volgograd; Volgograd

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Springer Science+Business Media New York, 2017